Introduction

Knee osteoarthritis (OA) is a common condition that causes pain and limits movement, affecting many people’s everyday lives. With growing interest in non-surgical treatments, two popular options have come to the fore: Arthrosamid and Platelet-Rich Plasma (PRP) injections. This article looks at how Arthrosamid stands out for its simplicity, predictability, and ease of use—qualities that matter greatly to both patients and healthcare professionals managing knee OA.

Understanding Knee Osteoarthritis and Patient Needs

Osteoarthritis in the knee occurs when the cartilage, the smooth tissue that cushions joints, gradually wears away. This leads to pain, stiffness, and difficulty with everyday activities such as walking or climbing stairs. People with knee OA often seek treatments that are easy to access, effective, and fit smoothly into their busy lives. Minimising the number of hospital visits and recovery time, while also providing reliable relief, is especially important for patients managing a long-term condition like OA.

How Arthrosamid and PRP Work

Arthrosamid is a gel-like substance made from polyacrylamide, which is injected directly into the knee joint. It acts as a cushion, reducing friction and providing support where natural cartilage has deteriorated. The procedure usually involves just one injection during a single visit, making it a straightforward option.

PRP treatment is a little more involved: blood is taken from the patient, processed in a lab to concentrate the platelets—tiny cells that help with healing—and then injected into the knee. Typically, PRP therapy requires several sessions over weeks or months.

While both treatments aim to reduce inflammation and ease pain, Arthrosamid’s “one-off” approach is often viewed as more predictable and convenient. It offers a simple routine that patients and clinicians can rely on.

It’s worth noting that recent research exploring PRP found umbilical cord-derived PRP to perform better in early knee OA than the standard blood-derived PRP, showing significant improvements in pain and function throughout a six-month period. This suggests that certain PRP formulations might be more effective, but the need for multiple visits remains a practical consideration.

Comparing Patient Experience: Simplicity and Accessibility

When considering how each treatment fits into patients’ lives, Arthrosamid stands out. Its single-appointment injection reduces the hassle of multiple visits often needed for PRP therapy. Patients receiving Arthrosamid usually experience a quick recovery, allowing them to get back to normal activities without lengthy downtime. This efficiency makes Arthrosamid particularly appealing to those seeking effective care with minimal disruption.

Predictability and Standardisation: Why It Matters

One of Arthrosamid’s key strengths is that it’s a standardised product, meaning each injection delivers a uniform dose and effect. This consistency contrasts with PRP, where the results can vary because of differences in how the plasma is prepared and individual patient factors.

A recent two-year study showed that Arthrosamid significantly improved symptoms in older, non-diabetic patients with milder forms of knee OA. The same research highlighted factors that increased the chance of a good outcome, including age, the severity of OA, absence of diabetes, and whether both knees were affected. For patients dealing with the unpredictable nature of osteoarthritis, knowing that treatment effects are consistent and reliable offers great reassurance.

Expert Care with Professor Paul Lee and MSK Doctors

The experience and skill of the treating team are just as important as the treatment itself. Professor Paul Lee, a leading orthopaedic surgeon specialising in cartilage care, along with the expert team at MSK Doctors, provide personalised, expert guidance at every step. Professor Lee has contributed to the latest research on Arthrosamid, bringing both expertise and a deep understanding of patient needs. Their approach helps build patient confidence and ensures treatments are tailored to each individual, setting a high standard for knee OA care.

Conclusion and Disclaimer

In summary, Arthrosamid offers an attractive solution for people with knee osteoarthritis who want treatment that is simple to receive, reliable in effect, and fits easily into daily life. Its one-off injection and standardised formulation provide practical benefits in convenience and consistency, making it a strong alternative to multi-visit therapies like PRP. However, every patient is different, and the best treatment depends on personal circumstances. For tailored medical advice, always consult a qualified healthcare professional.

References

Gao, H. C. K., Akhtar, M., Creedon, C., Verma, T., Nar, Ö. O., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma. https://doi.org/10.1016/j.jcot.2025.103136
Umer, M., Abdullah, M., Ali, L., Ahmad, K., & Mumtaz, K. (2025). Umbilical cord PRP is better in relieving pain in patients of knee osteoarthritis as compared to autologous venous PRP. Annals of Pims-Shaheed Zulfiqar Ali Bhutto Medical University, 21(3), 585-589. https://doi.org/10.48036/apims.v21i3.1506